About: Therapy with interleukin-2 induces the systemic release of phospholipase-A2

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Therapy with interleukin-2 induces the systemic release of phospholipase-A2 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 November 1995

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в листопаді 1995 (uk) im November 1995 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 01 November 1995 (en) artículu científicu espublizáu en payares de 1995 (ast)
publication date	wds:Q70823137-6F118A4A-7576-4A9F-8B25-5F4F4E8277C3
publication date	1995-11-01 00:00:00Z (xsd:dateTime)
exact match	wds:Q70823137-3B833A75-180C-4D7C-9964-CC0E350F31E2
exact match	https://scigraph.springernature.com/pub.10.1007/bf01517216
cites work	wds:Q70823137-05F76748-C24A-4167-8E22-85BE2CBF273A wds:Q70823137-0AD059DE-1331-4920-867C-FC327201B7B9 wds:Q70823137-0F497CA6-0D13-4FEE-AB7E-1C58ABBA4C9B wds:Q70823137-1A80BB02-8FA8-4CA2-8C5F-924738C7C915 wds:Q70823137-1DE72D46-06A7-4F4F-8185-60ACABFF40FF wds:Q70823137-1F5C01BA-0D97-4D28-BC3A-881F46F2695D wds:Q70823137-209DB73A-B84C-4000-A358-FAAA23F89A0C wds:Q70823137-21C9ECFE-7651-463E-A789-8DDE704443FA wds:Q70823137-2AF23F80-FD21-4FCA-89AE-70BC3CF99AF5 wds:Q70823137-32750203-CE60-45F6-8DF7-9179F227954A wds:Q70823137-336A4615-C4C7-454B-918B-18CEF28B9E28 wds:Q70823137-36702F2D-F9D4-4825-A412-8640EFC46030 wds:Q70823137-3A0E16A7-6732-4F07-B123-E48A6B1BCA95 wds:Q70823137-3D56261A-898A-4491-90A5-27D0EC3E1592 wds:Q70823137-3F7E97B5-2603-474B-9CC8-C1B56529657A wds:Q70823137-3FD571F0-6EC5-4B96-852E-A335366CAC61 wds:Q70823137-47D7026E-A5AA-467B-8B4B-001E3EA68176 wds:Q70823137-4B63E46B-27CE-49DA-B2CB-97E3A1B1ABCB wds:Q70823137-4EF71CDB-1BF2-4EA0-ACF2-ED4F68A3144F wds:Q70823137-51B0B918-87FA-4003-B6C0-7E2A1F68193B wds:Q70823137-567415CE-6CC2-4088-8A98-6990C6B346EC wds:Q70823137-5F10C03A-4F2E-412C-9740-F0B318C40C24 wds:Q70823137-66C6D2A2-2E49-4D8B-8C79-81DDD3DE048F wds:Q70823137-7A35CC9F-40C0-4340-83E2-66B52F3F214E wds:Q70823137-88B72E41-8305-4581-8B59-4EE0D004F3D6 wds:Q70823137-89E5A7CF-E461-46CA-81CC-1E108F38D916 wds:Q70823137-8E3E07B2-DBDB-4790-9A6A-ECA5A3066982 wds:Q70823137-D5B3F6CE-8945-4A50-9D88-FDA873937F9D wds:Q70823137-DCBC56D4-555C-492C-AFE4-76CE798C3132 wds:Q70823137-EDC601F4-E719-4CAC-B11C-E393698A3522 wds:Q70823137-EFA0693D-B75B-42E5-AF61-1E6DEECF9C68 wds:Q70823137-F6D8EB0D-1B50-42EA-90F3-367EC38DB242 wds:Q70823137-FCD27751-498C-41B8-A29A-E624B44CE9FA wds:Q70823137-FE775A6C-39EC-419B-A12D-38E03BF25C0A
cites work	Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis Increased synthesis and secretion of a 14-kDa phospholipase A2 by guinea pig alveolar macrophages. Dissociation from arachidonic acid liberation and modulation by dexamethasone Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response Serum phospholipases A2 in inflammatory diseases The hemodynamic effects of treatment with interleukin-2 and lymphokine-activated killer cells Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone IL-2 induces pulmonary edema and vasoconstriction independent of circulating lymphocytes. Pore-forming peptides induce rapid phospholipid flip-flop in membranes. Sensitive ELISA for interleukin-6. Detection of IL-6 in biological fluids: synovial fluids and sera Cytokine-stimulated secretion of group II phospholipase A2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy MEASUREMENT OF HUMAN PHOSPHOLIPASE A IN ARTHRITIS PLASMA USING A NEWLY DEVELOPED SANDWICH ELISA Phospholipase A2--a mediator between proximal and distal effectors of inflammation Recombinant secreted nonpancreatic phospholipase A2 induces a synovitis-like inflammation in the rat air pouch Adoptive immunotherapy of human cancer: the cytokine cascade and monocyte activation following high-dose interleukin 2 bolus treatment Isolation and properties of a phospholipase A1 activity from beef pancreas A review on methods of phospholipase a determination Synovial-type (group II) phospholipase A2 in serum of febrile patients with haematological malignancy Antisense inhibition of group II phospholipase A2 expression blocks the production of prostaglandin E2 by P388D1 cells. Induction of group II phospholipase A2 expression and pathogenesis of the sepsis syndrome. Association of hyperphospholipasemia A2 with multiple system organ dysfunction due to salicylate intoxication The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2. Interleukin-2 induces activation of coagulation and fibrinolysis: resemblance to the changes seen during experimental endotoxaemia Phospholipase A in acute lung injury after trauma and sepsis: its relation to the inflammatory mediators PMN-elastase, C3a, and neopterin Platelet activating factor mediates interleukin-2-induced lung injury in the rat Triggering of degranulation in mast cells by exogenous type II phospholipase A2 Peroxidation and phospholipase A2 hydrolytic susceptibility of liposomes consisting of mixed species of phosphatidylcholine and phosphatidylethanolamine Interleukin-2 therapy enhances salicylate oxidation by blood granulocytes Recombinant human type II phospholipase A2 lacks edema producing activity in rat Rat platelet phospholipase A2. Kinetic characterization using the monomolecular film technique Involvement of thromboxane and neutrophils in multiple-system organ edema with interleukin-2 Acute phase proteins and recombinant IL-2 therapy: prediction of response and survival in patients with colorectal cancer Are events after endotoxemia related to circulating phospholipase A2?
author name string	wds:Q70823137-64B5BE00-8457-4091-8ED3-1775352A0B46 wds:Q70823137-75DB64D7-0C2D-49CB-B59E-494313CFBAA5 wds:Q70823137-79DECD98-CBAD-4DFC-9E09-EF4E0C48291E wds:Q70823137-A985472F-28C4-4842-B9FA-D211BEEDBDA5 wds:Q70823137-F98B870E-9442-48A2-9F8C-69948184886A
author name string	H van den Bosch C E Hack J W Baars C Schalkwijk G J Wolbink
rdfs:label	Therapy with interleukin-2 induces the systemic release of phospholipase-A2 (en) Therapy with interleukin-2 induces the systemic release of phospholipase-A2 (nl)
skos:prefLabel	Therapy with interleukin-2 induces the systemic release of phospholipase-A2 (en) Therapy with interleukin-2 induces the systemic release of phospholipase-A2 (nl)
name	Therapy with interleukin-2 induces the systemic release of phospholipase-A2 (en) Therapy with interleukin-2 induces the systemic release of phospholipase-A2 (nl)
author	wds:Q70823137-1BBBBB99-CB0A-47CD-9E62-12F6D736133F
author	John Wagstaff
title	wds:Q70823137-8DCF910A-CE78-43AC-B015-760C4D3F252F
title	Therapy with interleukin-2 induces the systemic release of phospholipase-A2 (en)
page(s)	wds:Q70823137-EBD3431F-A963-480C-BBDC-0B1FCC94182F
page(s)	287-292

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 169 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software